Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6 and B12 for Vincristine Induced Neurotoxicity in ALL
NCT03593304Phase 3Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in neurotoxicity comparing Mecobalamin + Pyridoxine with Placebo (2 arms). Primary endpoints: Incidence of Vincristine Induced neurotoxicity at 5 weeks, Severity of Vincristine Induced neurotoxicity at 5 weeks and 1 more. Started Mar 2018; status: completed.
02
Drugs
mecobalaminpyridoxine
03
Conditions
neurotoxicity
Beyond the preview
Go deeper on NCT03593304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593304.